Current disease status-Recurrent cancer - Page 18 of 19 Posts on Medivizor
Navigation Menu

Current disease status-Recurrent cancer Posts on Medivizor

Evaluating the safety and efficacy of adding oxliplatin to fluoropyrimidine chemoradiotherapy before surgery in patients with locally advanced rectal cancer

Evaluating the safety and efficacy of adding oxliplatin to fluoropyrimidine chemoradiotherapy before surgery in patients with locally advanced rectal cancer

Posted by on May 31, 2013 in Colorectal cancer | 0 comments

In a nutshell This review compared the efficacy and risks associated with adding oxaliplatin (OX) to fluoropyimidine (FU) chemoradiotherapy (CRT) before surgery in patients with locally advanced rectal cancer (LARC).  Some background In LARC, the cancer has grown from the rectum (the lowest part of the large bowel) into surrounding...

Read More

Phase III clinical trial evaluating survival benefits of sequential versus concurrent docetaxel in doxorubicin-based chemotherapy in node-positive breast cancer patients

Phase III clinical trial evaluating survival benefits of sequential versus concurrent docetaxel in doxorubicin-based chemotherapy in node-positive breast cancer patients

Posted by on May 25, 2013 in Breast cancer | 0 comments

In a nutshell This phase III clinical trial evaluated the survival benefits after the addition of docetaxel into doxorubicin-based chemotherapy in node-positive breast cancer patients. Some background Node-positive breast cancer means that the cancer has spread to the lymph nodes near the breast such as under the arm or above the collarbone. Women...

Read More

Phase 3 clinical trial comparing intermittent hormonal therapy and continuous hormonal therapy in patients with advanced prostate cancer

Phase 3 clinical trial comparing intermittent hormonal therapy and continuous hormonal therapy in patients with advanced prostate cancer

Posted by on May 7, 2013 in Prostate cancer | 0 comments

In a nutshell The present study compared the effectiveness of two kinds of hormonal therapy in advanced prostate cancer (cancer that has spread beyond the prostate gland). These are intermittent hormonal therapy (IHT) and continuous androgen-deprivation therapy (ADT). In this study, IHT was similar to ADT in terms of survival, but showed better quality...

Read More

Evaluating relapse patterns in stage III melanoma patients

Evaluating relapse patterns in stage III melanoma patients

Posted by on Mar 30, 2013 in Melanoma | 0 comments

In a nutshell The present article evaluated the time interval and site of relapse (return of the cancer) as well as survival rates in stage III melanoma patients who were considered cured after treatment.  Some background Stage III melanoma is skin cancer that has spread to the nearby lymph nodes. Further classification (III A, III B and III...

Read More

New whole body treatments for advanced cutaneous cancer

New whole body treatments for advanced cutaneous cancer

Posted by on Mar 26, 2013 in Melanoma | 0 comments

In a nutshell This article published in 2013 reviews information from clinical studies which looked at new treatments for cutaneous melanoma.  These include drugs that aim to stimulate the body's anti-tumor immune response, such as ipilimumab (Yervoy) and tremelimumab and those that target genetic mutations in cancer cells. Some background...

Read More

Bosutinib: a new drug that increases progression free survival in patients with locally advanced or metastatic breast cancer

Bosutinib: a new drug that increases progression free survival in patients with locally advanced or metastatic breast cancer

Posted by on Mar 11, 2013 in Breast cancer | 0 comments

In a nutshell This paper presents the results of a clinical study which looked at the use of a new drug called Bosutinib (Bosulif) for the treatment of breast cancers diagnosed as being stage III or IV. In patients previously treated with chemotherapy, Bosutinib showed promising efficacy in delaying cancer progression. Some background Locally...

Read More

Radiofrequency ablation may slow down the progression of metastatic colorectal cancer

Radiofrequency ablation may slow down the progression of metastatic colorectal cancer

Posted by on Mar 5, 2013 in Colorectal cancer | 0 comments

In a nutshell This report aimed to establish if radiofrequency ablation (RFA) of liver metastases originating from colorectal cancer (CRC) provides any benefits to patients with Stage IV of the disease. Main result: RFA extends progression-free survival by 7 months. Some background RFA is a medical procedure for treating patients with small tumors...

Read More

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Comparison of two surgical techniques for the treatment of pseudomyxoma peritonei

Posted by on Mar 4, 2013 in Colorectal cancer | 1 comment

In a nutshell The present study compared the efficacy of two surgical techniques to treat pseudomyxoma peritonei (PMP): debulking and cytoreduction. Cytoreductive surgery achieved better surgical results and yielded higher 3- and 5-year survival rates, compared with debulking. Some background PMP is a rare condition caused by the production of...

Read More

Evaluating cancer outcomes and safety of laparoscopic prostatectomy in patients with recurrent prostate cancer

Evaluating cancer outcomes and safety of laparoscopic prostatectomy in patients with recurrent prostate cancer

Posted by on Mar 3, 2013 in Prostate cancer | 0 comments

In a nutshell The present study evaluated the safety, adverse effects and cancer outcomes of Salvage Robotic Assisted Laparoscopic Radical Prostatectomy (sRALP) in patients with recurrent prostate cancer. The procedure was surgically safe, yet 18% of the patients had another recurrence within 16 months of surgery. Some background...

Read More

Safety and efficacy of radical prostatectomy for men with locally recurrent prostate cancer

Safety and efficacy of radical prostatectomy for men with locally recurrent prostate cancer

Posted by on Mar 3, 2013 in Prostate cancer | 0 comments

In a nutshell The present review evaluated the efficacy, safety and complications of salvage radical prostatectomy in patients with locally recurrent prostate cancer, and sought for the ideal candidates for this procedure. Some background Prostate cancer (PCa) is the most common type of cancer in men. Treatment options for PCa which is confined to...

Read More

The association between insulin blood levels and risk of death in breast cancer patients

Posted by on Feb 28, 2013 in Breast cancer | 0 comments

In a nutshell The present study evaluated the relationship between high insulin levels in the blood stream and the risk of cancer-related mortality. Its authors report that women with higher-than-normal insulin levels are at higher risk of death due to breast cancer. Some background Breast cancer has been shown to be more common in people who...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor